ENHANCING NEONATAL HYPERBILIRUBINEMIA MANAGEMENT: A COMMUNITY SERVICE PROGRAM AT RSUD AJI BATARA DEWA SAKTI
Downloads
This study details an intervention through a community service conducted at the Regional General Hospital Aji Batara Agung Dewa Sakti, focusing on the improvement of healthcare professional’s skills in managing neonatal hyperbilirubinemia. The program conducted in two days, including a one-day socialization and one-day training session. Comprehensive approach was used with a special emphasis on the BiliNorm application. The intervention result shows higher score in post test compared to pre-test, indicating significant improvements (P<0.001) in participant’s knowledge and skills. Statistical analysis highlighted the effectiveness of the training program in demonstrating a successful transfer of knowledge on the usage of BiliNorm application, AirBiliSun and AirBiliNest. This study highlighted the positive impact of this program on early detection and management practices.
Bhutani VK, Vilms RJ, Hamerman-Johnson L. 2010. “Universal bilirubin screening for severe neonatal hyperbilirubinemia.” J Perinatol. https://pubmed.ncbi.nlm.nih.gov/20877410/.
Darling E.K., Guttmann A., Sprague A.E., Ramsay T., Walker M.C. 2014. “Implementation of the Canadian Paediatric Society's hyperbilirubinemia guidelines: a survey of Ontario hospitals.” Pediatr Child Health 19: 133-137.
Kemper AR, Newman TB, Slaughter JL, et al. 2022. “Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation.” Pediatrics. https://doi.org/10.1542/peds.2022-058859 PMID: 35927462.
Kuzniewicz MW, Park J, Niki H, Walsh EM, McCulloch CE, Newman TB. 2021 “Predicting the Need for Phototherapy After Discharge.” Pediatrics. 147(5) https://doi.org/10.1542/peds.2020-019778 PMID: 33903163.
Maisels MJ. “The clinical approach to the jaundiced newborn.” In: Maisels MJ. 2000. Neonatal Jaundice. Amsterdam: Harwood Academic Publishers. h.139-68.
American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. Jul 2024; 114(1):297–316. https://doi.org/10.1542/peds.114.1.297. PMID:15231951.
Pan DH, Rivas Y. 2017. “Jaundice: Newborn to Age 2 Months.” Pediatr Rev. 38(11):499–510. https://doi.org/10.1542/pir.2015-0132 PMID: 29093118.
Petrova A, Mehta R, Birchwood G, Ostfeld B, Hegyi T. 2006. “Management of neonatal hyperbilirubinemia: pediatricians’ practices and educational needs.” BMC Pediatr. https://pubmed.ncbi.nlm.nih.gov/16519797/.
Porter ML, Dennis BL. 2002. Hyperbilirubinemia in the term newborn. Am Fam Physician. Feb 15 2002; 65 (4):599–606. PMID: 11871676.
Rohsiswatmo R, Amandito R. 2018. “Hiperbilirubinemia pada Neonatus >35 Minggu di Indonesia; Pemeriksaan dan Tatalaksana Terkini [Hyperbilirubinemia in Neonates >35 Weeks in Indonesia; Current Examination and Management].” Sari Pediatr 20(2):115.
Sampurna MTA, Ratnasari KA, Etika R, Hulzebos C V., Dijk PH, Bos AF, et al. 2018. “Adherence to Hyperbilirubinemia Guidelines by Midwives, General Practitioners, and Pediatricians in Indonesia.” PLoS One. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0196076.
Sgro M., Kandasamy S., Shah V., Ofner M., Campbell D. 2016. “Severe neonatal hyperbilirubinemia decreased after the 2007 Canadian guidelines.” J. Pediatr 171: 43-47.
Shaughnessy E, Goyal N. 2020. “Digestive System Disorders.” In: Kliegman R, Geme JS, Blum N, Shah S, eds. Nelson Textbook of Pediatrics. Elsevier 949–961:chap 123.
Copyright (c) 2024 Mahendra Tri Arif Sampurna, Hidayat Niko Azhari , Zida Husnina, Muhammad Rizky Widodo, Syah Reza Budi Azhari
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
JLM by Unair is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions
3. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution Share-Alike (CC BY-SA).
4. The Creative Commons Attribution Share-Alike (CC BY-SA) license allows re-distribution and re-use of a licensed work on the conditions that the creator is appropriately credited and that any derivative work is made available under "the same, similar or a compatible license”. Other than the conditions mentioned above, the editorial board is not responsible for copyright violation.
